| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |